Product Name | CBA |
Description |
TRPM4 channel blocker |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 351424-20-9 |
Molecular Formula | C15H11Cl2NO4 |
Molecular Weight | 340.2 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Blocker |
Solubility | May be dissolved in DMSO (35 mg/ml) |
Source | Synthetic |
Appearance | Off-white powder |
SMILES | C1=CC=C(C(=C1)OCC(=O)NC2=C(C=CC(=C2)Cl)C(=O)O)Cl |
InChI | InChI=1S/C15H11Cl2NO4/c16-9-5-6-10(15(20)21)12(7-9)18-14(19)8-22-13-4-2-1-3-11(13)17/h1-7H,8H2,(H,18,19)(H,20,21) |
InChIKey | CVQCJPCMPGKEDH-UHFFFAOYSA-N |
Safety Phrases | Not a hazardous substance or mixture. |
Cite This Product | CBA (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-633) |
Alternative Names | 4-Chloro-2-[[2-(2-chlorophenoxy)acetyl]amino]benzoic acid; TRPM4-IN-5 |
Research Areas | Ion Channels, Neuroscience, Neurotransmission, Transient Receptor Potential (TRP) Channels |
PubChem ID | 2264067 |
Scientific Background | CBA is a selective blocker of TRPM4 channels (IC50 = 1.5 M) with no activity at TRPM5, TRPM7, TRPM8, TRPV1, TRPV3, TRPV6 and a panel of other ion channels and receptors (1). Displays protective effects in murine experimental autoimmune encephalomyelitis and in a model of glutamate-induced neuronal degeneration (2). A highly useful tool for exploring the functions of TRM4 in a variety of cell types (3,4). |
References |
1.,LC Ozhathil et al. Br. J. Pharmacol. 2018 175:2504 2.,B Bianchi et al. Mol. Brain 2018 11:41 3.,A Borgstrom et al. J. Mol. Biol. 2021 433:166665 4.,G Diszhazi et al. J. Biol. Chem. 2021 297:101015 |
Reviews
There are no reviews yet.